Literature DB >> 25792533

Diffusion Tensor Imaging Mapping of Brain White Matter Pathology in Mitochondrial Optic Neuropathies.

D N Manners1, G Rizzo2, C La Morgia3, C Tonon1, C Testa1, P Barboni4, E Malucelli5, M L Valentino3, L Caporali3, D Strobbe3, V Carelli6, R Lodi7.   

Abstract

BACKGROUND AND
PURPOSE: Brain white matter is frequently affected in mitochondrial diseases; optic atrophy gene 1-autosomal dominant optic atrophy and Leber hereditary optic neuropathy are the most frequent mitochondrial monosymptomatic optic neuropathies. In this observational study, brain white matter microstructure was characterized by DTI in patients with optic atrophy gene 1-autosomal dominant optic atrophy and Leber hereditary optic neuropathy, in relation to clinical and genetic features.
MATERIALS AND METHODS: Nineteen patients with optic atrophy gene 1-autosomal dominant optic atrophy and 17 with Leber hereditary optic neuropathy older than 18 years of age, all genetically diagnosed, and 19 healthy volunteers underwent DTI by using a 1.5T MR imaging scanner and neurologic and ophthalmologic assessments. Brain white matter DTI metrics were calculated for all participants, and, in patients, their correlations with genetics and clinical findings were calculated.
RESULTS: Compared with controls, patients with optic atrophy gene 1-autosomal dominant optic atrophy had an increased mean diffusivity in 29.2% of voxels analyzed within major white matter tracts distributed throughout the brain, while fractional anisotropy was reduced in 30.3% of voxels. For patients with Leber hereditary optic neuropathy, the proportion of altered voxels was only 0.5% and 5.5%, respectively, of which half was found within the optic radiation and 3.5%, in the smaller acoustic radiation. In almost all regions, fractional anisotropy diminished with age in patients with optic atrophy gene 1-autosomal dominant optic atrophy and correlated with average retinal nerve fiber layer thickness in several areas. Mean diffusivity increased in those with a missense mutation. Patients with Leber hereditary optic neuropathy taking idebenone had slightly milder changes.
CONCLUSIONS: Patients with Leber hereditary optic neuropathy had preferential involvement of the optic and acoustic radiations, consistent with trans-synaptic degeneration, whereas patients with optic atrophy gene 1-autosomal dominant optic atrophy presented with widespread involvement suggestive of a multisystemic, possibly a congenital/developmental, disorder. White matter changes in Leber hereditary optic neuropathy and optic atrophy gene 1-autosomal dominant optic atrophy may be exploitable as biomarkers.
© 2015 by American Journal of Neuroradiology.

Entities:  

Mesh:

Year:  2015        PMID: 25792533      PMCID: PMC7965282          DOI: 10.3174/ajnr.A4272

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  39 in total

Review 1.  Diffusion-tensor MR imaging and tractography: exploring brain microstructure and connectivity.

Authors:  Paolo G P Nucifora; Ragini Verma; Seung-Koo Lee; Elias R Melhem
Journal:  Radiology       Date:  2007-11       Impact factor: 11.105

2.  Idebenone treatment in Leber's hereditary optic neuropathy.

Authors:  Valerio Carelli; Chiara La Morgia; Maria Lucia Valentino; Giovanni Rizzo; Michele Carbonelli; Anna Maria De Negri; Federico Sadun; Arturo Carta; Silvana Guerriero; Francesca Simonelli; Alfredo Arrigo Sadun; Divya Aggarwal; Rocco Liguori; Patrizia Avoni; Agostino Baruzzi; Massimo Zeviani; Pasquale Montagna; Piero Barboni
Journal:  Brain       Date:  2011-08-02       Impact factor: 13.501

3.  Subclinical multisystem neurologic disease in "pure" OPA1 autosomal dominant optic atrophy.

Authors:  M R Baker; K M Fisher; R G Whittaker; P G Griffiths; P Yu-Wai-Man; P F Chinnery
Journal:  Neurology       Date:  2011-09-14       Impact factor: 9.910

4.  Mathematically modeling the involvement of axons in Leber's hereditary optic neuropathy.

Authors:  Billy X Pan; Fred N Ross-Cisneros; Valerio Carelli; Kelly S Rue; Solange R Salomao; Milton N Moraes-Filho; Milton N Moraes; Adriana Berezovsky; Rubens Belfort; Alfredo A Sadun
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-11-09       Impact factor: 4.799

5.  Methodological considerations on tract-based spatial statistics (TBSS).

Authors:  Michael Bach; Frederik B Laun; Alexander Leemans; Chantal M W Tax; Geert J Biessels; Bram Stieltjes; Klaus H Maier-Hein
Journal:  Neuroimage       Date:  2014-06-16       Impact factor: 6.556

Review 6.  Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies.

Authors:  Patrick Yu-Wai-Man; Philip G Griffiths; Patrick F Chinnery
Journal:  Prog Retin Eye Res       Date:  2010-11-26       Impact factor: 21.198

7.  Multi-system neurological disease is common in patients with OPA1 mutations.

Authors:  P Yu-Wai-Man; P G Griffiths; G S Gorman; C M Lourenco; A F Wright; M Auer-Grumbach; A Toscano; O Musumeci; M L Valentino; L Caporali; C Lamperti; C M Tallaksen; P Duffey; J Miller; R G Whittaker; M R Baker; M J Jackson; M P Clarke; B Dhillon; B Czermin; J D Stewart; G Hudson; P Reynier; D Bonneau; W Marques; G Lenaers; R McFarland; R W Taylor; D M Turnbull; M Votruba; M Zeviani; V Carelli; L A Bindoff; R Horvath; P Amati-Bonneau; P F Chinnery
Journal:  Brain       Date:  2010-02-15       Impact factor: 13.501

8.  Progressive auditory neuropathy in patients with Leber's hereditary optic neuropathy.

Authors:  B Ceranić; L M Luxon
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-04       Impact factor: 10.154

9.  Mitochondrial rhomboid PARL regulates cytochrome c release during apoptosis via OPA1-dependent cristae remodeling.

Authors:  Sara Cipolat; Tomasz Rudka; Dieter Hartmann; Veronica Costa; Lutgarde Serneels; Katleen Craessaerts; Kristine Metzger; Christian Frezza; Wim Annaert; Luciano D'Adamio; Carmen Derks; Tim Dejaegere; Luca Pellegrini; Rudi D'Hooge; Luca Scorrano; Bart De Strooper
Journal:  Cell       Date:  2006-07-14       Impact factor: 41.582

10.  Mutation of OPA1 causes dominant optic atrophy with external ophthalmoplegia, ataxia, deafness and multiple mitochondrial DNA deletions: a novel disorder of mtDNA maintenance.

Authors:  Gavin Hudson; Patrizia Amati-Bonneau; Emma L Blakely; Joanna D Stewart; Langping He; Andrew M Schaefer; Philip G Griffiths; Kati Ahlqvist; Anu Suomalainen; Pascal Reynier; Robert McFarland; Douglass M Turnbull; Patrick F Chinnery; Robert W Taylor
Journal:  Brain       Date:  2007-12-07       Impact factor: 13.501

View more
  12 in total

1.  Visual pathways evaluation in Kearns Sayre syndrome: a diffusion tensor imaging study.

Authors:  Maria Camilla Rossi-Espagnet; Martina Lucignani; Luca Pasquini; Antonio Napolitano; Stefano Pro; Andrea Romano; Daria Diodato; Diego Martinelli; Daniela Longo
Journal:  Neuroradiology       Date:  2019-11-04       Impact factor: 2.804

2.  Probabilistic Fiber-Tracking Reveals Degeneration of the Contralateral Auditory Pathway in Patients with Vestibular Schwannoma.

Authors:  S M Rueckriegel; G A Homola; M Hummel; N Willner; R-I Ernestus; C Matthies
Journal:  AJNR Am J Neuroradiol       Date:  2016-06-02       Impact factor: 3.825

3.  Brain white matter changes in asymptomatic carriers of Leber's hereditary optic neuropathy.

Authors:  Miaomiao Long; Ling Wang; Qin Tian; Hao Ding; Wen Qin; Dapeng Shi; Chunshui Yu
Journal:  J Neurol       Date:  2019-03-25       Impact factor: 4.849

Review 4.  A neurodegenerative perspective on mitochondrial optic neuropathies.

Authors:  Patrick Yu-Wai-Man; Marcela Votruba; Florence Burté; Chiara La Morgia; Piero Barboni; Valerio Carelli
Journal:  Acta Neuropathol       Date:  2016-09-30       Impact factor: 17.088

5.  Comparative Analysis of Lipid Extracts and Imaging Mass Spectrometry for Evaluating Cerebral White Matter Biochemical Pathology in an Experimental Second-Hand Cigarette Smoke Exposure Model.

Authors:  Alexander Krotow; Emine B Yalcin; Jared Kay; Suzanne M de la Monte
Journal:  Mass Spectrom Purif Tech       Date:  2016-04-20

6.  Therapeutic effects of the mitochondrial ROS-redox modulator KH176 in a mammalian model of Leigh Disease.

Authors:  Ria de Haas; Devashish Das; Alejandro Garanto; Herma G Renkema; Rick Greupink; Petra van den Broek; Jeanne Pertijs; Rob W J Collin; Peter Willems; Julien Beyrath; Arend Heerschap; Frans G Russel; Jan A Smeitink
Journal:  Sci Rep       Date:  2017-09-15       Impact factor: 4.379

7.  Diffusivity and quantitative T1 profile of human visual white matter tracts after retinal ganglion cell damage.

Authors:  Hiromasa Takemura; Shumpei Ogawa; Aviv A Mezer; Hiroshi Horiguchi; Atsushi Miyazaki; Kenji Matsumoto; Keigo Shikishima; Tadashi Nakano; Yoichiro Masuda
Journal:  Neuroimage Clin       Date:  2019-04-16       Impact factor: 4.881

Review 8.  Molecular Biomarkers in Multiple Sclerosis and Its Related Disorders: A Critical Review.

Authors:  Maryam Gul; Amirhossein Azari Jafari; Muffaqam Shah; Seyyedmohammadsadeq Mirmoeeni; Safee Ullah Haider; Sadia Moinuddin; Ammar Chaudhry
Journal:  Int J Mol Sci       Date:  2020-08-21       Impact factor: 5.923

9.  A multiple sclerosis-like disorder in patients with OPA1 mutations.

Authors:  Patrick Yu-Wai-Man; Achillefs Spyropoulos; Holly J Duncan; Joseph V Guadagno; Patrick F Chinnery
Journal:  Ann Clin Transl Neurol       Date:  2016-07-19       Impact factor: 4.511

Review 10.  Optic neuropathies: the tip of the neurodegeneration iceberg.

Authors:  Valerio Carelli; Chiara La Morgia; Fred N Ross-Cisneros; Alfredo A Sadun
Journal:  Hum Mol Genet       Date:  2017-10-01       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.